Cavalier Investments, LLC Exelixis, Inc. Transaction History

Cavalier Investments, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 10, 2018	SELL	$22.15 - $31.89 $959,094 - $1.38 Million	-43,300 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$24.23 - $30.93 $278,645 - $355,695	11,500 Added 36.16%	43,300 $1.32 Million
Q3 2017 Nov 02, 2017	BUY	$23.35 - $29.24 $742,530 - $929,832	31,800	31,800 $771,000

503

244M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Cavalier Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Cavalier Investments, LLC with notifications on news.